Abstract
Uterine leiomyomas (LMs) are the most common tumors in women. They can cause severe morbidity. Treatment of LMs is individualized based on the severity of the symptoms, the size and location of the leiomyoma lesions, the patient’s age and their chronological proximity to menopause, and the patient’s desire for future fertility. The gold standard of leiomyoma treatment is surgery. Hysterectomy is the definitive surgical operation, but myomectomy is still commonly performed especially in women who desire future fertility. More recently developed techniques, which include uterine artery embolization (UAE), magnetic resonance-guided focused ultrasound surgery (MRgFUS), and myolysis, are emerging as minimally invasive alternative procedures. LMs tend to recur in different parts of the uterus. There are no definitive therapeutic agents for the treatment of uterine LMs. Therefore, there is a need for new treatments. Understanding the molecular mechanisms which are involved in the development of these tumors is very important for developing new treatment modalities. This study is an important study as it addresses an important molecular mechanism in the development of LMs. It is known that LM growth requires the maintenance and proliferation of a stem cell population. Dysregulated deoxyribonucleic acid (DNA) methylation has been reported in LM, but its role in LM stem cell regulation remains unclear. In this study, the authors have investigated the effect of DNA methylation in LMs. They have observed an inverse relationship between methylation and gene expression changes during LSC differentiation. In LSC, hypermethylation suppressed the genes important for myometrium- and LM-associated functions, including muscle contraction and hormone action, to maintain stemness. They have shown that hypomethylating drug, 5'-Aza, stimulated LSC differentiation, depleting the stem cell population and inhibiting tumor initiation. Thus, they have suggested that DNA methylation maintains the pool of LSC, which is critical for the regeneration of LM tumors.